AIM ImmunoTech Inc. (AIM) Earnings History
Annual and quarterly earnings data from 1995 to 2024
Loading earnings history...
AIM EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
AIM Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 81.8% | -11630.6% | -10188.2% |
| 2023 | 79.2% | -15800.0% | -14337.6% |
| 2022 | 400.7% | -14129.7% | -13790.8% |
| 2021 | -529.6% | -13954.1% | -14168.1% |
| 2020 | -394.5% | -9295.7% | -8834.4% |
Download Data
Export AIM earnings history in CSV or JSON format
Free sign-in required to download data
AIM ImmunoTech Inc. (AIM) Earnings Overview
As of May 8, 2026, AIM ImmunoTech Inc. (AIM) reported trailing twelve-month net income of -$16M, reflecting +48.3% year-over-year growth. The company earned $-7.52 per diluted share over the past four quarters, with a net profit margin of -10188.2%.
Looking at the long-term picture, AIM's historical earnings data spans multiple years. The company achieved its highest annual net income of -$2M in fiscal 1995.
AIM ImmunoTech Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including IMMP (-$104M net income, -1218.0% margin), NKTR (-$164M net income, -297.1% margin), IOVA (-$354M net income, -148.4% margin), AIM has room to improve margins relative to the peer group. Compare AIM vs IMMP →
AIM Earnings vs Peers
Earnings metrics vs comparable public companies
AIM Historical Earnings Data (1995–2024)
30 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$17M | +40.2% | -$20M | $-0.31 | -10188.2% | -11630.6% |
| 2023 | -$29M | -48.9% | -$32M | $-0.60 | -14337.6% | -15800.0% |
| 2022 | -$19M | -1.7% | -$20M | $-0.44 | -13790.8% | -14129.7% |
| 2021 | -$19M | -32.8% | -$19M | $-0.45 | -14168.1% | -13954.1% |
| 2020 | -$14M | -33.0% | -$15M | $-0.51 | -8834.4% | -9295.7% |
| 2019 | -$11M | -10.3% | -$12M | $-2.97 | -7732.9% | -8887.9% |
| 2018 | -$10M | -18.8% | -$11M | $-9.77 | -2673.8% | -3132.4% |
| 2017 | -$8M | -10.1% | -$11M | $-12.67 | -1889.9% | -2612.4% |
| 2016 | -$8M | +50.7% | -$14M | $-15.13 | -8154.3% | -15004.3% |
| 2015 | -$15M | +12.7% | -$17M | $-34.05 | -11451.1% | -12518.8% |
See AIM's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs AIM Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare AIM vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonAIM — Frequently Asked Questions
Quick answers to the most common questions about buying AIM stock.
Is AIM growing earnings?
AIM EPS is $-7.52, with earnings growth accelerating to +48.3%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-16M.
What are AIM's profit margins?
AIM ImmunoTech Inc. net margin is -10188.2%, with operating margin at -11630.6%. Below-average margins reflect competitive or cost pressures.
How consistent are AIM's earnings?
AIM earnings data spans 1995-2024. The accelerating earnings trend is +48.3% YoY. Historical data enables comparison across business cycles.